Literature DB >> 3877112

Superior portosystemic collateral circulation estimated by azygos blood flow in patients with cirrhosis. Lack of correlation with oesophageal varices and gastrointestinal bleeding. Effect of propranolol.

P Calès, A Braillon, M I Jirón, D Lebrec.   

Abstract

In patients with cirrhosis, superior portosystemic collateral circulation was evaluated by the continuous thermodilution method in the azygos vein. Azygos blood flow was 5 times higher in a group of patients with cirrhosis (alcoholic in 27, cryptogenic in 8, post-hepatitic in 2 and primary biliary cirrhosis in 1), than in a group of patients without portal hypertension (steatosis in 2, granulomatous hepatitis in 2, persistent chronic hepatitis in 2 and Hodgkin's disease in 1). Azygos blood flow was not different in cirrhotic patients with no visible, in those with small-sized, and in those with large sized oesophageal varices. Azygos blood flow was not different in cirrhotic patients with and without a previous episode of gastrointestinal bleeding. Fifteen min after intravenous administration of 15 mg of propranolol, azygos blood flow significantly decreased whereas azygos blood flow did not change after placebo. The decrease in azygos blood flow was significantly more marked than the reduction in cardiac output. It is concluded that superior portosystemic collateral blood flow is elevated in patients with cirrhosis and that the reduction in this collateral circulation might explain the efficiency of propranolol in the prevention of recurrent gastrointestinal bleeding.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3877112     DOI: 10.1016/s0168-8278(85)80066-0

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  13 in total

1.  Computerised system for the continuous measurement of azygos venous blood flow.

Authors:  P C Hayes; D Terrace; I Peaston; I A Bouchier; D Redhead; H M Brash
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

Review 2.  Current management of the complications of portal hypertension: variceal bleeding and ascites.

Authors:  Nina Dib; Frédéric Oberti; Paul Calès
Journal:  CMAJ       Date:  2006-05-09       Impact factor: 8.262

3.  Effects of non-shunting operation on azygos venous blood flow in cirrhotic patients.

Authors:  N Kokudo; S Kawasaki; K Ohashi; H Sakamoto; H Koyama; K Sanjo; Y Idezuki
Journal:  Gut       Date:  1989-10       Impact factor: 23.059

Review 4.  Radioisotopic splenoportography in patients with portal hypertension.

Authors:  N Samejima; K Ikeda; Y Yokoyama; S Hirata
Journal:  Jpn J Surg       Date:  1989-05

5.  Influence of the degree of liver failure on systemic and splanchnic haemodynamics and on response to propranolol in patients with cirrhosis.

Authors:  A Braillon; P Cales; D Valla; D Gaudy; P Geoffroy; D Lebrec
Journal:  Gut       Date:  1986-10       Impact factor: 23.059

Review 6.  The medical prevention of variceal bleeding.

Authors:  D Lebrec
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

7.  Hemodynamic effects of the early and long-term administration of propranolol in rats with intrahepatic portal hypertension.

Authors:  Lionel Fizanne; Nicolas Régenet; Jianhua Wang; Frédéric Oberti; Frédéric Moal; Jerôme Roux; Yves Gallois; Sophie Michalak; Paul Calès
Journal:  Hepatol Int       Date:  2008-04-12       Impact factor: 6.047

8.  Prophylaxis of first variceal hemorrhage in patients with liver cirrhosis.

Authors:  T Sauerbruch; G Kleber; A Gerbes; G Paumgartner
Journal:  Klin Wochenschr       Date:  1986-12-15

9.  Hepatic intestinal uptake and release of catecholamines in alcoholic cirrhosis. Evidence of enhanced hepatic intestinal sympathetic nervous activity.

Authors:  J H Henriksen; H Ring-Larsen; N J Christensen
Journal:  Gut       Date:  1987-12       Impact factor: 23.059

10.  Wedged hepatic venous pressure reflects portal venous pressure during vasoactive drug administration in nonalcoholic cirrhosis.

Authors:  T Iwao; A Toyonaga; M Ikegami; M Sumino; K Oho; M Sakaki; H Shigemori; M Nakayama; K Tanikawa
Journal:  Dig Dis Sci       Date:  1994-11       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.